End-of-day quote
Santiago S.E.
06:00:00 2024-04-28 pm EDT
|
5-day change
|
1st Jan Change
|
6,510
CLP
|
-.--%
|
|
-.--%
|
-.--%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
124,434
|
125,431
|
136,877
|
161,764
|
158,031
|
162,025
|
Enterprise Value (EV)
1 |
154,148
|
154,092
|
171,376
|
206,609
|
218,960
|
212,613
|
P/E ratio
|
8.73
x
|
8.03
x
|
7.94
x
|
7.81
x
|
5.44
x
|
6.78
x
|
Yield
|
4.02%
|
11.3%
|
10.2%
|
6.17%
|
9.5%
|
10.2%
|
Capitalization / Revenue
|
0.8
x
|
0.83
x
|
0.87
x
|
0.85
x
|
0.6
x
|
0.75
x
|
EV / Revenue
|
0.98
x
|
1.01
x
|
1.08
x
|
1.08
x
|
0.83
x
|
0.99
x
|
EV / EBITDA
|
6.51
x
|
6.29
x
|
6.64
x
|
6.59
x
|
5.68
x
|
6.29
x
|
EV / FCF
|
130
x
|
77.4
x
|
24.1
x
|
-2,150
x
|
-43.9
x
|
11.9
x
|
FCF Yield
|
0.77%
|
1.29%
|
4.15%
|
-0.05%
|
-2.28%
|
8.39%
|
Price to Book
|
1.68
x
|
1.5
x
|
1.75
x
|
1.91
x
|
1.6
x
|
1.51
x
|
Nbr of stocks (in thousands)
|
24,887
|
24,887
|
24,887
|
24,887
|
24,887
|
24,887
|
Reference price
2 |
5,000
|
5,040
|
5,500
|
6,500
|
6,350
|
6,510
|
Announcement Date
|
3/28/19
|
3/27/20
|
3/27/21
|
3/31/22
|
3/31/23
|
3/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
156,502
|
152,021
|
158,135
|
191,128
|
264,695
|
214,649
|
EBITDA
1 |
23,673
|
24,481
|
25,800
|
31,354
|
38,532
|
33,807
|
EBIT
1 |
19,340
|
20,378
|
21,548
|
26,830
|
34,141
|
28,136
|
Operating Margin
|
12.36%
|
13.4%
|
13.63%
|
14.04%
|
12.9%
|
13.11%
|
Earnings before Tax (EBT)
1 |
19,171
|
20,952
|
22,902
|
27,252
|
37,392
|
31,608
|
Net income
1 |
14,239
|
15,604
|
17,219
|
20,702
|
29,060
|
23,896
|
Net margin
|
9.1%
|
10.26%
|
10.89%
|
10.83%
|
10.98%
|
11.13%
|
EPS
2 |
572.6
|
627.5
|
692.4
|
832.5
|
1,168
|
960.2
|
Free Cash Flow
1 |
1,182
|
1,992
|
7,110
|
-96.08
|
-4,992
|
17,830
|
FCF margin
|
0.76%
|
1.31%
|
4.5%
|
-0.05%
|
-1.89%
|
8.31%
|
FCF Conversion (EBITDA)
|
4.99%
|
8.14%
|
27.56%
|
-
|
-
|
52.74%
|
FCF Conversion (Net income)
|
8.3%
|
12.76%
|
41.29%
|
-
|
-
|
74.62%
|
Dividend per Share
2 |
201.0
|
571.0
|
560.0
|
401.0
|
603.0
|
663.0
|
Announcement Date
|
3/28/19
|
3/27/20
|
3/27/21
|
3/31/22
|
3/31/23
|
3/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
29,714
|
28,660
|
34,499
|
44,846
|
60,929
|
50,588
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.255
x
|
1.171
x
|
1.337
x
|
1.43
x
|
1.581
x
|
1.496
x
|
Free Cash Flow
1 |
1,182
|
1,992
|
7,110
|
-96.1
|
-4,992
|
17,830
|
ROE (net income / shareholders' equity)
|
19.8%
|
19.8%
|
21.3%
|
25.4%
|
31.9%
|
23.2%
|
ROA (Net income/ Total Assets)
|
8.68%
|
8.45%
|
8.29%
|
9.18%
|
10.2%
|
7.82%
|
Assets
1 |
164,139
|
184,756
|
207,753
|
225,404
|
285,594
|
305,439
|
Book Value Per Share
2 |
2,985
|
3,363
|
3,145
|
3,409
|
3,971
|
4,323
|
Cash Flow per Share
2 |
166.0
|
281.0
|
395.0
|
387.0
|
292.0
|
384.0
|
Capex
1 |
9,230
|
14,788
|
21,643
|
11,336
|
12,533
|
12,834
|
Capex / Sales
|
5.9%
|
9.73%
|
13.69%
|
5.93%
|
4.73%
|
5.98%
|
Announcement Date
|
3/28/19
|
3/27/20
|
3/27/21
|
3/31/22
|
3/31/23
|
3/28/24
|
|
1st Jan change
|
Capi.
|
---|
| -.--% | 169M | | +2.65% | 78.54B | | +0.77% | 46.91B | | -5.76% | 30.31B | | +12.30% | 18.58B | | -10.05% | 11.56B | | +5.14% | 11.11B | | -7.50% | 9.81B | | +6.40% | 9.69B | | +5.61% | 9.3B |
Diversified Chemicals
|